Distribution punchline: Vietnam’s pharmaceutical distribution system looks simple on paper: manufacturer to national distributor to provincial distributor to pharmacy. In practice, it is a layered system where the real gate-keepers are the hospital procurement committees and the pharmacy chain buyers, not the wholesale distributors. International brands who understand this get listed faster and stay listed longer.
Vietnam’s pharmaceutical and health product market grew 12% in 2025, reaching USD 8.1 billion in total market value. The combination of an aging population (7.7% of Vietnamese are over 65, a figure rising fast), rising per-capita income, and persistent trust in imported pharmaceutical brands over domestic generics makes Vietnam one of Southeast Asia’s most commercially attractive health markets for international brands. But the distribution infrastructure is specific, regulated, and relationship-dependent.
The five distribution layers in Vietnam’s pharmaceutical sector
Layer 1: National pharmaceutical distributors (Dược Hà Tây, Vimedimex, Zuellig Pharma Vietnam, Mega Lifesciences). These are the importers who hold the import licenses and maintain the primary relationship with Vietnam’s Ministry of Health and the Drug Administration of Vietnam (DAV). For most international pharmaceutical and health product brands, one of these national distributors is the first-step partner.
Layer 2: Provincial and regional distributors. Vietnam’s 63 provinces each have their own pharmaceutical distribution infrastructure. National distributors supply provincial distributors who in turn supply the pharmacy and clinical channel within their province. For brands wanting tier-2 and tier-3 city coverage beyond HCMC and Hanoi, the provincial distributor relationship is essential and often overlooked by international brands who focus only on national-level agreements.
Layer 3: Hospital procurement. Government hospitals in Vietnam procure through a formal tender system (bidding committees) that evaluates price, clinical documentation, and registered product status. International pharmaceutical brands entering Vietnam’s hospital channel need local registration, clinical evidence documentation in Vietnamese, and typically a national distributor with active hospital tender experience. This channel is slower to develop but generates the highest volume per SKU once a brand is established.
Layer 4: Pharmacy chains. Long Chau (1,800+ locations), Pharmacity (1,100+ locations), An Khang (900+ locations), and Medicare. These chains are the fastest-growing pharmaceutical retail channel in Vietnam, expanding aggressively into tier-2 cities. International OTC health products and supplement brands enter Vietnam primarily through pharmacy chains rather than hospital procurement. The pharmacy chain buyers are sophisticated and require DAV registration, competitive pricing, and co-marketing investment.
Layer 5: Traditional pharmacy (nha thuoc). Vietnam’s traditional independent pharmacy network is estimated at 60,000+ individual pharmacy outlets nationwide. These are still the dominant pharmaceutical channel in rural and semi-urban areas. Traditional pharmacies are served by provincial distributors and local wholesalers. For brands wanting national reach, traditional pharmacy coverage requires a distributor with provincial wholesaler relationships, not just modern pharmacy chain connections.
The regulatory prerequisite: DAV registration
Every pharmaceutical and health supplement product sold in Vietnam requires either a full DAV drug registration (for pharmaceutical drugs) or a MOH health food notification (for supplements and OTC health products). The choice between pharmaceutical registration and supplement notification determines your entire distribution channel strategy. Pharmaceutical drug registration allows hospital procurement eligibility but takes 12 to 36 months and costs USD 10,000 to 50,000 per product. Health supplement notification is faster (4 to 8 weeks) and cheaper (USD 500 to 2,000 per SKU) but excludes hospital procurement channels. Choose your regulatory pathway based on your channel strategy, not just your product classification.
The four national distributors international brands work with
Zuellig Pharma Vietnam: the most international-oriented of Vietnam’s national pharmaceutical distributors. They have the widest hospital channel relationships and the most documented experience with imported brand representation. Their terms are professional but their minimum volume requirements are high for brands entering Vietnam with limited product range.
Mega Lifesciences: specializes in OTC health products and supplements alongside prescription pharmaceuticals. Strong pharmacy chain relationships. Relevant for international brands positioned between pharmaceutical drug and supplement.
Vimedimex: a large Vietnamese-owned national distributor with strong government hospital and provincial distributor relationships. Relevant for brands wanting to enter Vietnam’s public sector hospital channel rather than primarily the pharmacy chain channel.
DKSH Vietnam: the distribution arm of Swiss market expansion group DKSH with strong modern trade and pharmacy relationships across all of Southeast Asia. For international brands already working with DKSH in other Asian markets, the Vietnam extension through existing DKSH relationships is often the fastest route to market.
Case study: Swiss pharmaceutical brand enters Long Chau in 9 months
A Swiss OTC pharmaceutical brand (digestive health category, strong EU registration) came to Asia Pro in early 2025 wanting to enter Vietnam’s pharmacy channel without full pharmaceutical drug registration, which would have required 18 to 24 months. Their product qualified for health supplement notification (MOH) rather than full DAV registration, which compressed the regulatory timeline significantly.
We connected them with Mega Lifesciences Vietnam, who had existing Long Chau and Pharmacity buyer relationships and experience with European OTC health products. DAV notification submitted in week 4. Mega Lifesciences Long Chau buyer introduction at week 6. First Long Chau listing confirmed at month 8. Year-one Vietnam pharmacy channel revenue: USD 165,000. Long Chau reorder volume at month 12 confirmed year-two expansion to An Khang network.
The lesson: the regulatory pathway choice (pharmaceutical drug versus supplement notification) determines your time to market more than any other single decision in Vietnam’s health product distribution. Spend USD 500 on a regulatory classification consultation before assuming you need full pharmaceutical registration.
Case study: Australian vitamin brand gets listed then loses the listing
An Australian vitamin brand entered Vietnam through a HCMC-based pharmaceutical distributor in 2022. The distributor got them into 120 independent pharmacies (nha thuoc) in HCMC through their wholesale network. Initial sell-through was acceptable. But the brand provided no co-marketing support, no KOL health content, and no in-store display materials. After 8 months, the independent pharmacies stopped reordering because pharmacist recommendation (which drives 60% of purchases in traditional Vietnamese pharmacies) was not supporting the brand. Without pharmacist endorsement or consumer pull, the product sat on the shelf.
The brand switched distributors 14 months into their Vietnam operation. The new distributor had pharmacy chain relationships but also ran pharmacist education sessions: 30-minute product briefings for pharmacy staff at new locations. Sell-through in pharmacy chain locations with pharmacist briefings was 3 times the rate of locations without them. The pharmacist channel is not passive in Vietnam. It is the primary recommendation engine for OTC health products.
The lesson: in Vietnam’s traditional pharmacy channel, the pharmacist’s recommendation drives purchase decisions more than consumer advertising. Any OTC health product distribution strategy in Vietnam needs a pharmacist education component alongside consumer-facing KOL content.
What KOLs and social media say about pharmaceutical and health products in Vietnam
Vietnamese health content on TikTok and YouTube is heavily influenced by a community of medical doctors and pharmacists who have built personal content creator followings. These “medical KOLs” (bac si/duoc si content creators) carry significantly more purchase credibility than celebrity health endorsements. A product reviewed positively by a Vietnamese medical doctor with 200,000 YouTube followers generates pharmacy sell-through that advertising cannot replicate. International pharmaceutical and health brands that engage Vietnamese medical professional content creators as part of their market entry strategy consistently outperform brands relying on standard beauty/wellness KOL content.
Facebook’s Vietnamese health community groups (groups focused on specific conditions: diabetes, hypertension, immunity, bone health) are where Vietnamese patients and caregivers share product experiences. A product mentioned positively in these communities by a credible member generates word-of-mouth that flows into pharmacy recommendations. Brands with genuinely effective products who engage these communities authentically (through clinical content, not promotional posts) build brand credibility that pays off in pharmacy sell-through.
FAQ: Pharmaceutical distribution in Vietnam
Do I need DAV drug registration to sell OTC health products in Vietnam?
Not necessarily. Products positioned as health supplements (functional food) use MOH health food notification rather than DAV drug registration. The key distinction is whether your product makes specific therapeutic claims (requires DAV registration) or general health claims (eligible for MOH notification). Many OTC products that require pharmaceutical registration in Europe can be reclassified as health supplements in Vietnam if their claims are adjusted accordingly. A Vietnamese regulatory consultant can assess your specific product in 2 to 3 business days and recommend the fastest compliant pathway.
How do I get a product listed on the Long Chau or Pharmacity buyer’s radar?
Long Chau and Pharmacity buyers receive hundreds of new product proposals monthly. The ones that get meetings share: completed MOH/DAV registration, documented sell-through data from at least one Asian market (South Korea and Australia are the most credible references for Vietnamese pharmacy buyers), a Vietnamese-language product information sheet with clinical backing, and a co-marketing investment budget for the first quarter. Cold approaches without these elements rarely generate meetings. A warm introduction through a qualified distributor who already supplies the chain converts to a meeting at 5 to 10 times the rate of direct brand outreach.
What margin do Vietnamese pharmaceutical distributors require?
National pharmaceutical distributors (Zuellig, Mega, Vimedimex, DKSH) typically require 20 to 35% margin on CIF Vietnam cost. Pharmacy chains require 25 to 40% gross margin on their purchase price from the distributor. The combined distribution and retail margin means international health product brands need to price at 2.5 to 3.5 times their Vietnam CIF cost to reach a viable end-consumer price. This sounds wide but is consistent with premium health product pricing in Vietnamese pharmacy channels, where consumers already expect premium international brand pricing.
How long does full pharmaceutical drug registration in Vietnam take in 2026?
DAV pharmaceutical drug registration: 18 to 36 months from application to approval, depending on product category and documentation completeness. Vietnam has recently implemented an expedited review pathway for products with EU, US FDA, or Australian TGA registration: expedited review targets 12 to 18 months. The expedited pathway requires submitting the complete dossier from the reference country’s regulatory approval simultaneously with the Vietnam application. Brands pursuing hospital procurement in Vietnam have no alternative to full DAV registration. The timeline is fixed. Plan your market entry accordingly.
Entering Vietnam’s Health and Pharmaceutical Market?
Asia Pro Distribution connects international health and pharmaceutical brands with qualified Vietnamese distributors, regulatory consultants, and pharmacy chain buyers.
Vietnam health distribution — Distribution services — Contact our team
